‌

US Patent 11542256 Vinylheterocycles as Rho-associated coiled-coil kinase (ROCK) inhibitors

Patent 11542256 was granted and assigned to Angion Biomedica Corp. on January, 2023 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Patent Applicant

Angion Biomedica Corp.

Current Assignee

Angion Biomedica Corp.

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

115422560

Patent Inventor Names

Swarnalatha Paka0

Dong Sung Lim0

Itzhak D. Goldberg0

Prakash Narayan0

Quaisar Ali0

Satishkumar Gadhiya0

An-Hu Li0

Dawoon Jung0

...

Date of Patent

January 3, 2023

Patent Application Number

166438050

Date Filed

August 31, 2018

Patent Citations

‌

US Patent 10183931 Rho kinase inhibitors

‌

US Patent 10570123 Pharmacokinetically improved compounds

Patent Primary Examiner

CPC Code

The present invention provides compounds having formula (I): and pharmaceutically acceptable salts thereof, wherein Cy1, Cy2, Cy3, R, R

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11542256 Vinylheterocycles as Rho-associated coiled-coil kinase (ROCK) inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API